miR-221 suppression through nanoparticle-based miRNA delivery system for hepatocellular carcinoma therapy and its diagnosis as a potential biomarker
Feng Li,1,* Feiran Wang,2,* Changlai Zhu,3 Qun Wei,1 Tianyi Zhang,1 You Lang Zhou4 1Department of Gastroenterology, 2Department of General Surgery, Affiliated Hospital of Nantong University, 3Key Laboratory of Neuroregeneration, Nantong University, 4The Hand Surgery Research Center, Department of H...
Main Authors: | Li F, Wang F, Zhu C, Wei Q, Zhang T, Zhou YL |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/mir-221-suppression-through-nanoparticle-based-mirna-delivery-system-f-peer-reviewed-article-IJN |
Similar Items
-
miR-221 Suppression Through Nanoparticle-Based miRNA Delivery System for Hepatocellular Carcinoma Therapy and Its Diagnosis as a Potential Biomarker [Corrigendum]
by: Li F, et al.
Published: (2020-10-01) -
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
by: Maria Teresa Di Martino, et al.
Published: (2020-06-01) -
EGFR Signaling Pathway and Related-miRNAs In Age-related Diseases: The Example of miR-221 and miR-222
by: Ana L Teixeira, et al.
Published: (2012-12-01) -
Increased MiR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis <it>in vitro</it>
by: Rong Minhua, et al.
Published: (2013-01-01) -
Expression of miR⁃21, miR⁃221, and miR⁃222 in exosomes of CAL27 tongue squamous cell carcinoma cells
by: HUANG Wenxi, et al.
Published: (2018-04-01)